Paper478692
Selective cytotoxicity of tunicamycin for transformed cells.
Olden K and 2 others. Int J Cancer, 1979. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Selective cytotoxicity of tunicamycin for transformed cells. Papers, record 478692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/478692
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Cell Survival | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Glucosamine | Major topic |
| Tunicamycin | Major topic |
| Animals | |
| Cell Line | |
| Chick Embryo | |
| DNA | |
| DNA, Neoplasm | |
| Deoxyglucose | |
| Drug Evaluation, Preclinical | |
| Fibroblasts | |
| Glucose | |
| Humans | |
| Mice | |
| Rats |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926240 | Molecular insights into GPR55 modulation reveal an atypical activation mechanism and glycosylation-dependent efficacy regulation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42926240 | PubMed |
| 7204487 | Inhibition of fusion of embryonic muscle cells in culture by tunicamycin is prevented by leupeptin. | J Cell Biol | 1981 | https://conductscience.org/library/papers/7204487 | PubMed |
| 6971575 | Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin. | Am J Pathol | 1981 | https://conductscience.org/library/papers/6971575 | PubMed |
| 6933558 | Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933558 | PubMed |
| 3731247 | Response of malignant and nonmalignant epidermal cell lines to tunicamycin. | Cell Tissue Res | 1986 | https://conductscience.org/library/papers/3731247 | PubMed |
| 3081900 | Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3081900 | PubMed |
| 2991743 | Inhibition of the formation of lipid-linked intermediates in normal and transformed cells by a purified tunicamycin homologue. | Mol Cell Biochem | 1985 | https://conductscience.org/library/papers/2991743 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/478692
GET https://conductscience.org/api/papers/v1/478692/authors